Pure Bioscience Price Prediction
| PUREDelisted Stock | USD 0.09 0.03 26.83% |
Oversold Vs Overbought
51
Oversold | Overbought |
Using Pure Bioscience hype-based prediction, you can estimate the value of Pure Bioscience from the perspective of Pure Bioscience response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Pure Bioscience to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Pure because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Pure Bioscience after-hype prediction price | USD 0.09 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Pure |
Pure Bioscience After-Hype Price Prediction Density Analysis
As far as predicting the price of Pure Bioscience at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Pure Bioscience or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Pure Bioscience, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Pure Bioscience Estimiated After-Hype Price Volatility
In the context of predicting Pure Bioscience's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Pure Bioscience's historical news coverage. Pure Bioscience's after-hype downside and upside margins for the prediction period are 0.08 and 0.09, respectively. We have considered Pure Bioscience's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Pure Bioscience is very steady at this time. Analysis and calculation of next after-hype price of Pure Bioscience is based on 3 months time horizon.
Pure Bioscience Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Pure Bioscience is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Pure Bioscience backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Pure Bioscience, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 0 Events / Month | 4 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.09 | 0.09 | 2.51 |
|
Pure Bioscience Hype Timeline
Pure Bioscience is at this time traded for 0.09. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Pure is projected to increase in value after the next headline, with the price projected to jump to 0.09 or above. The average volatility of media hype impact on the company the price is insignificant. The price growth on the next news is estimated to be 2.51%, whereas the daily expected return is at this time at 0.0%. The volatility of related hype on Pure Bioscience is about 0.0%, with the expected price after the next announcement by competition of 0.09. Pure Bioscience currently holds 239 K in liabilities with Debt to Equity (D/E) ratio of 0.09, which may suggest the company is not taking enough advantage from borrowing. Given the investment horizon of 90 days the next projected press release will be within a week. Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.Pure Bioscience Related Hype Analysis
Having access to credible news sources related to Pure Bioscience's direct competition is more important than ever and may enhance your ability to predict Pure Bioscience's future price movements. Getting to know how Pure Bioscience's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Pure Bioscience may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| KMB | Kimberly Clark | 0.53 | 7 per month | 0.00 | (0.16) | 1.18 | (1.76) | 6.34 | |
| CL | Colgate Palmolive | 0.50 | 9 per month | 0.00 | (0.22) | 1.30 | (1.74) | 6.33 | |
| UL | Unilever PLC ADR | 0.41 | 7 per month | 0.00 | (0.23) | 1.08 | (1.31) | 6.60 | |
| EL | Estee Lauder Companies | 0.38 | 10 per month | 0.00 | (0.11) | 4.62 | (3.42) | 30.90 | |
| CLX | The Clorox | (2.43) | 10 per month | 0.68 | (0.01) | 1.48 | (1.44) | 4.64 |
Pure Bioscience Additional Predictive Modules
Most predictive techniques to examine Pure price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Pure using various technical indicators. When you analyze Pure charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Pure Bioscience Predictive Indicators
The successful prediction of Pure Bioscience stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Pure Bioscience, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Pure Bioscience based on analysis of Pure Bioscience hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Pure Bioscience's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Pure Bioscience's related companies.
Story Coverage note for Pure Bioscience
The number of cover stories for Pure Bioscience depends on current market conditions and Pure Bioscience's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Pure Bioscience is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Pure Bioscience's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Pure Bioscience Short Properties
Pure Bioscience's future price predictability will typically decrease when Pure Bioscience's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Pure Bioscience often depends not only on the future outlook of the potential Pure Bioscience's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Pure Bioscience's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 88 M |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Consideration for investing in Pure Pink Sheet
If you are still planning to invest in Pure Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pure Bioscience's history and understand the potential risks before investing.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |